CD10-targeted CAR-T immunotherapy 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
4SCAR-T / SZGIMI
NCT04637503: 4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Recruiting
1/2
100
RoW
GD2, PSMA and CD276 CAR-T cells
Shenzhen Geno-Immune Medical Institute, Shenzhen Children's Hospital
Neuroblastoma
11/20
12/23
NCT04016129: CAR-T Immunotherapy Targeting CD19- ALL

Recruiting
1/2
100
RoW
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR
Shenzhen Geno-Immune Medical Institute
B-cell Leukemia
07/21
12/23
NCT04430595: Multi-4SCAR-T Therapy Targeting Breast Cancer

Recruiting
1/2
100
RoW
4SCAR T cells
Shenzhen Geno-Immune Medical Institute, The Seventh Affilliated Hospital, Sun Yat-Sen University
Breast Cancer
05/23
12/23
NCT04430530: 4SCAR-T Therapy Post CD19-targeted Immunotherapy

Recruiting
1/2
100
RoW
Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20
Shenzhen Geno-Immune Medical Institute, ShiJiaZhuang Zhongxi Children Hospital, Shenzhen Children's Hospital, The Seventh Affilliated Hospital, Sun Yat-Sen University
CD19 Negative B-cell Malignancies
05/23
12/23
NCT05459870: CAR-T Cells Targeting Autoimmune Diseases

Recruiting
1/2
30
RoW
4SCAR T cells
Shenzhen Geno-Immune Medical Institute, Guilin Hospital of Chinese Traditional and Western Medicine
Autoimmune Diseases
07/25
06/26
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR / SZGIMI
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
4SCAR-T / SZGIMI
NCT04637503: 4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Recruiting
1/2
100
RoW
GD2, PSMA and CD276 CAR-T cells
Shenzhen Geno-Immune Medical Institute, Shenzhen Children's Hospital
Neuroblastoma
11/20
12/23
NCT04016129: CAR-T Immunotherapy Targeting CD19- ALL

Recruiting
1/2
100
RoW
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR
Shenzhen Geno-Immune Medical Institute
B-cell Leukemia
07/21
12/23
NCT04430595: Multi-4SCAR-T Therapy Targeting Breast Cancer

Recruiting
1/2
100
RoW
4SCAR T cells
Shenzhen Geno-Immune Medical Institute, The Seventh Affilliated Hospital, Sun Yat-Sen University
Breast Cancer
05/23
12/23
NCT04430530: 4SCAR-T Therapy Post CD19-targeted Immunotherapy

Recruiting
1/2
100
RoW
Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20
Shenzhen Geno-Immune Medical Institute, ShiJiaZhuang Zhongxi Children Hospital, Shenzhen Children's Hospital, The Seventh Affilliated Hospital, Sun Yat-Sen University
CD19 Negative B-cell Malignancies
05/23
12/23
NCT05459870: CAR-T Cells Targeting Autoimmune Diseases

Recruiting
1/2
30
RoW
4SCAR T cells
Shenzhen Geno-Immune Medical Institute, Guilin Hospital of Chinese Traditional and Western Medicine
Autoimmune Diseases
07/25
06/26
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR / SZGIMI
No trials found

Download Options